Evidence map›Paper›PMID 36553398›Full record

ArticleChildren (Basel, Switzerland)2022

Lessons Learned from the Impact of HIV Status Disclosure to Children after First-Line Antiretroviral Treatment Failure in Kinshasa, DR Congo.

Faustin Nd Kitetele, Gilbert M Lelo, Cathy E Akele, Patricia V M Lelo, Loukia Aketi, Eric M Mafuta, Thorkild Tylleskär, Espérance Kashala-Abotnes

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Faustin Nd KiteteleDepartment of Infectious Diseases, Kalembelembe Pediatric Hospital, Kinshasa 012, Democratic Republic of the Congo.ORCID 0000-0002-6963-8825
Gilbert M LeloCentre Neuro-Psycho-Pathologique de Kinshasa (CNPP), Faculty of Medicine, University of Kinshasa, Kinshasa 012, Democratic Republic of the Congo.
Cathy E AkeleDepartment of Infectious Diseases, Kalembelembe Pediatric Hospital, Kinshasa 012, Democratic Republic of the Congo.
Patricia V M LeloDepartment of Infectious Diseases, Kalembelembe Pediatric Hospital, Kinshasa 012, Democratic Republic of the Congo.
Loukia AketiPediatric Department, Faculty of Medicine, University of Kinshasa, Kinshasa 012, Democratic Republic of the Congo.ORCID 0000-0002-3266-7489
Eric M MafutaKinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa 012, Democratic Republic of the Congo.
Thorkild TylleskärCentre for International Health (CIH), Faculty of Medicine, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0003-4801-4324
Espérance Kashala-AbotnesCentre for International Health (CIH), Faculty of Medicine, University of Bergen, 5020 Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV status disclosure to children remains a challenge in sub-Saharan Africa. For sociocultural reasons, parents often delay disclosure with subsequent risks to treatment compliance and the child’s psychological well-being. This article assesses the effects of HIV disclosure on second-line ART compliance after first-line failure. We conducted a retrospective study of 52 HIV-positive children at Kalembelembe Pediatric Hospital in Kinshasa who were unaware of their HIV status and had failed to respond to the first-line ART. Before starting second-line ART, some parents agreed to disclosure. All children were followed before and during the second-line ART. Conventional usual descriptive statistics were used. For analysis, the children were divided into two groups: disclosed to (n = 39) and not disclosed to (n = 13). Before starting the second-line ART, there was no difference in CD4 count between the two groups (p = 0.28). At the end of the first year of second-line ART, the difference was statistically significant between the two groups with regard to CD4% (p < 0.001) and deaths (p = 0.001). The children disclosed to also reported fewer depressive symptoms post-disclosure and had three times fewer clinic visits. HIV status disclosure to children is an important determinant of ART compliance and a child’s psychological well-being.

Indexed as

antiretroviral therapy failurecompliancedepressiondisclosureHIVpediatrics

Identifiers

PMID36553398
PMCPMC9777424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.